Provided by Tiger Trade Technology Pte. Ltd.

Milestone Pharmaceuticals Inc.

1.04
-0.1100-9.57%
Post-market: 1.040.00000.00%19:51 EDT
Volume:2.94M
Turnover:3.18M
Market Cap:122.72M
PE:-1.38
High:1.15
Open:1.15
Low:1.03
Close:1.15
52wk High:3.06
52wk Low:0.6254
Shares:118.00M
Float Shares:67.59M
Volume Ratio:0.85
T/O Rate:4.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7517
EPS(LYR):-0.6674
ROE:-229.65%
ROA:-41.08%
PB:2.94
PE(LYR):-1.56

Loading ...

Apr 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Mar 21, 2024

Major Issues Report

Form 8-K - Current report
Mar 21, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Feb 26, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 30, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 26, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Oct 24, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]